Research Interests
Research Interests
Dr. Green’s Biomaterials and Drug Delivery Laboratory is interested in biomaterials, drug delivery, gene therapy, nanobiotechnology, and cell engineering. Research findings — and the technologies developed — are applied in the fields of ophthalmology, oncology, and regenerative medicine.
The lab works within the chemistry/biology/engineering interface to answer fundamental scientific questions, and to create innovative technologies and therapeutics that can directly benefit human health.
Current projects include:
- Development of safe and effective biodegradable nanoparticles for DNA and siRNA delivery to treat cancer
- Polymeric microparticle-based biological treatments for age-related macular degeneration
- Design of biomimetic artificial antigen presenting cells for immunoengineering
- Enabling technologies for tissue engineering and regenerative medicine
Titles & Affiliations
Titles
- Herschel L. Seder Professor, Biomedical Engineering
- Vice Chair for Research and Translation, Department of Biomedical Engineering
- Professor, Ophthalmology
- Professor, Oncology
- Professor, Neurosurgery
- Professor, Materials Science & Engineering
- Professor, Chemical & Biomolecular Engineering
Affiliated Centers & Institutes
Education
Education
- PhD, Biological Engineering, Massachusetts Institute of Technology, 2007
- BS, Chemical Engineering, Biomedical Engineering, Carnegie Mellon University, 2003
Faculty News
Recent Highlights
-
April 30, 2026The award honors researchers who apply basic scientific principles to solve critical challenges in biomaterials.
-
November 19, 2025Biomedical engineer Jordan Green talks with The Associated Press about his research to alter dysfunctional immune systems.
-
August 8, 2025Three Johns Hopkins experts discuss the potential of mRNA-powered therapeutics to produce lifesaving treatments and cures for a range of diseases, and why federal research cuts risk undermining U.S. scientific leadership in this emerging area.
Media
